Clinical Trial Update: Safety and Efficacy of TRx0237 in Subjects With Alzheimer's Disease Followed by Open-Label Treatment [Phase 3]

View source ↗

Summary

This is a Phase 3 clinical trial update reporting safety and efficacy results for TRx0237 in Alzheimer's disease, including an open-label treatment phase after …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease

Drugs mentioned

• TRx0237

Snippet

Sponsor: TauRx Therapeutics Ltd | Conditions: Alzheimer Disease | Phase 3 | Status: COMPLETED | Results posted: 2025-09-04